Ardelyx Inc. (ARDX) Financial Statements (2026 and earlier)

Company Profile

Business Address 34175 ARDENWOOD BLVD.
FREMONT, CA 94555
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:250,100184,299123,909116,689186,484247,492
Cash and cash equivalent64,93221,47096,14072,42891,032181,133
Short-term investments185,168162,82927,76944,26195,45266,379
Other undisclosed cash, cash equivalents, and short-term investments      (20)
Receivables57,70522,0317,733502  
Inventory, net of allowances, customer advances and progress billings91,18449,48728,346   
Inventory91,18449,48728,346   
Contract with customer, asset, after allowance for credit loss      750
Other undisclosed current assets(42,537)(9,706)(6,385)16,4588,2023,820
Total current assets:356,452246,111153,603133,649194,686252,062
Noncurrent Assets
Inventory, Noncurrent70,01137,03925,064   
Operating lease, right-of-use asset2,3805,5899,29512,7522,2743,970
Property, plant and equipment1,4951,0091,2232,3621,9363,436
Long-term investments and receivables     2,114 
Long-term investments     2,114 
Other noncurrent assets5,4163,5968811,150552314
Other undisclosed noncurrent assets  4,235    
Total noncurrent assets:79,30251,46836,46316,2646,8767,720
TOTAL ASSETS:435,754297,579190,066149,913201,562259,782
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities30,94023,73518,4079,90211,2986,640
Interest and dividends payable203  
Employee-related liabilities5,4225,6724,453
Accounts payable16,00011,13810,8594,2775,6262,187
Accrued liabilities14,94012,5977,548   
Deferred revenue10,6867,1824,211   
Debt   26,71132,2646,2843,791
Other liabilities 8,7571,366885605285749
Other undisclosed current liabilities27,44718,11015,38910,05010,54911,040
Total current liabilities:77,83050,39365,60352,82128,41622,220
Noncurrent Liabilities
Long-term debt and lease obligation150,85349,822 9,74847,03450,907
Long-term debt, excluding current maturities150,85349,822  46,62148,831
Liabilities, other than long-term debt8,25510,36914,8804,727  
Deferred revenue7,2328,6449,0254,727  
Operating lease, liability1,0231,7255,8559,7484132,076
Other undisclosed noncurrent liabilities25,52720,17911,254   
Total noncurrent liabilities:184,63580,37026,13414,47547,03450,907
Total liabilities:262,465130,76391,73767,29675,45073,127
Equity
Equity, attributable to parent173,289166,81698,32982,617126,112186,655
Common stock2423201399
Additional paid in capital1,058,5481,012,773878,500795,540680,872647,078
Accumulated other comprehensive income (loss)57224(54)(6)(4)20
Accumulated deficit(885,340)(846,204)(780,137)(712,930)(554,765)(460,452)
Total equity:173,289166,81698,32982,617126,112186,655
TOTAL LIABILITIES AND EQUITY:435,754297,579190,066149,913201,562259,782

Income Statement (P&L) ($ in thousands)

9/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues333,615124,45652,15810,0977,5715,281
Cost of revenue(50,556)(17,795)(4,117)(1,000)(145)(600)
Cost of product and service sold(50,556)(17,795)    
Gross profit:283,059106,66148,0419,0977,4264,681
Operating expenses(311,009)(169,937)(111,800)(163,443)(98,206)(95,944)
Operating loss:(27,950)(63,276)(63,759)(154,346)(90,780)(91,263)
Nonoperating income9,1746,6301,6336871,5682,352
Interest and debt expense(13,006)(4,950)(3,400)(4,502)(5,099)(5,726)
Loss from continuing operations before equity method investments, income taxes:(31,782)(61,596)(65,526)(158,161)(94,311)(94,637)
Other undisclosed loss from continuing operations before income taxes(7,088)(3,924)(1,673)   
Loss from continuing operations before income taxes:(38,870)(65,520)(67,199)(158,161)(94,311)(94,637)
Income tax expense(266)(547)(8)(4)(2)(303)
Loss from continuing operations:(39,136)(66,067)(67,207)(158,165)(94,313)(94,940)
Loss before gain (loss) on sale of properties:(158,165)(94,313)(94,940)
Net loss available to common stockholders, diluted:(39,136)(66,067)(67,207)(158,165)(94,313)(94,940)

Comprehensive Income ($ in thousands)

9/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(39,136)(66,067)(67,207)(158,165)(94,313)(94,940)
Comprehensive loss:(39,136)(66,067)(67,207)(158,165)(94,313)(94,940)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(167)278(48)(2)(24)58
Comprehensive loss, net of tax, attributable to parent:(39,303)(65,789)(67,255)(158,167)(94,337)(94,882)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: